Rising Demand for Pet Health: Predicted $13.2 Billion Pet OTC Medication Market by 2032

The Pet OTC Medication Market is poised to reach a valuation of US$ 8.5 Billion in 2022. Sales are projected to increase at a 4.5% CAGR, with the market size reaching US$ 13.2 Billion by 2032.

The global  pet OTC   (over-the-counter) medication is forecast to grow at a steady rate during the assessment period. Rising pet adoption across the globe is expected to push sales in the market through 2032. Increasing awareness regarding pet healthcare has also made a significant contribution to the growth in pet OTC medication market.

Emerging markets in low and middle-income countries are expected to offer opportunities for expansion. In addition to this, surging demand for herbal topical medication for fleas and other allergies in pets will boost sales in the market.

“Rising availability of pet insurance in countries such as the U.S. and France, along with increasing demand for natural ingredient-based pet care products is expected to fuel the growth in the market over the assessment period,” says an FMI analyst.

Take Action: Gain Valuable Insights into the Rising Investments and Market Growth of Pet OTC Medication – Download Our Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-15353

Key Takeaways:

  • Demand for natural ingredients-based medications is expected to gain traction at a considerable pace.
  • Chewables and tablets will account for nearly 30% of the total market share over the forecast period.
  • Total sales of OTC medicines for dogs will hold approximately 40% of the global pet OTC medication market share.
  • The U.S. will continue dominating the North America pet OTC medication market over the assessment period, with sales growing at a 2% CAGR.
  • Demand in the India market is forecast to surge at a 5.5% CAGR through 2032.
  • France will account for a lion’s share in the Europe pet OTC medication market over the forecast period.

Competition Landscape

The key players in the pet OTC medication market are Ceva Santé Animale Co., Elanco Animal Health Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co., Inc., Virbac SA Co., Bayer AG, IDEXX Laboratories Co., Covetrus Inc., Dechra Pharmaceuticals PLC, Vetoquinol SA, Phibro Animal Health Co., Kyoritsuseiyaku Co., Krka, d. d., Novo Mesto, Sequent Scientific Ltd., Heska Co., Eco Animal Health Group, and Neogen Co.

Unlock Bespoke Analysis: Request Customized Insights to Fuel Your Success in the Pet OTC Medication Market! https://www.futuremarketinsights.com/customization-available/rep-gb-15353

Pet OTC Medication Market by Category

Pet Type:

  • Dogs
  • Cats
  • Birds
  • Fish and Reptiles
  • Small Pets
  • Others

Application:

  • Fleas & Ticks
  • Allergies
  • Pain Relief & Arthritis
  • De-wormers
  • Others

Form:

  • Chewables & Tablets
  • Capsules & Ointment
  • Sprays
  • Others

Sales Channel:

  • Pet Specialty Stores
  • Veterinary Clinics
  • Drug & Pharmacy Stores
  • Online Retail
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these